Owner Amgen Inc.

Inventors Smith, Andrew; Cushing, Timothy D.; Mcminn, Dustin L.; Kopecky, David J.; Farthing, Christopher N.; Jiao, Xian Yun; Smith, Marie-Louise; DeGraffenreid, Michael R.; Rasmussen, Sven P.; Lively, Sarah E.; Jaen, Juan C.; Cardozo, Mario G.; Shin, Youngsook; Hao, Xiaolin; Burkitt, Simon A.; Labelle, Marc

Agent Spruson & Ferguson

Pub. Number AU-B-2003270701

PCT Number PCT/US03/29143

PCT Pub. Number WO2004/041285

Priority 60/422,531 31.10.02 US

Filing date 19 September 2003

Wipo publication date 7 June 2004

Acceptance publication date 12 November 2009

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 239/74 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 495/14 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or